Trial Profile
A Randomized, Double-Blind, Placebo Controlled, Parallel Group, Single Dose Study of the Safety and Efficacy of Subcutaneously Administered REGN475 in Patients With Osteoarthritis of the Knee.
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase II
Latest Information Update: 25 Mar 2015
Price :
$35
*